Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1973 2
1974 1
1975 1
1976 2
1977 1
1980 1
1982 1
1990 4
1991 5
1992 1
1993 6
1994 5
1995 5
1996 8
1997 14
1998 12
1999 14
2000 13
2001 23
2002 7
2003 24
2004 8
2005 19
2006 27
2007 22
2008 24
2009 24
2010 23
2011 21
2012 38
2013 33
2014 27
2015 26
2016 28
2017 39
2018 49
2019 59
2020 58
2021 59
2022 67
2023 55
2024 59
2025 24

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

842 results

Results by year

Filters applied: . Clear all
Page 1
Neoadjuvant Nivolumab for Patients With Resectable Merkel Cell Carcinoma in the CheckMate 358 Trial.
Topalian SL, Bhatia S, Amin A, Kudchadkar RR, Sharfman WH, Lebbé C, Delord JP, Dunn LA, Shinohara MM, Kulikauskas R, Chung CH, Martens UM, Ferris RL, Stein JE, Engle EL, Devriese LA, Lao CD, Gu J, Li B, Chen T, Barrows A, Horvath A, Taube JM, Nghiem P. Topalian SL, et al. J Clin Oncol. 2020 Aug 1;38(22):2476-2487. doi: 10.1200/JCO.20.00201. Epub 2020 Apr 23. J Clin Oncol. 2020. PMID: 32324435 Free PMC article. Clinical Trial.
Retifanlimab: First Approval.
Kang C. Kang C. Drugs. 2023 Jun;83(8):731-737. doi: 10.1007/s40265-023-01884-7. Drugs. 2023. PMID: 37184754 Review.
Progressive Multifocal Leukoencephalopathy Treated by Immune Checkpoint Inhibitors.
Boumaza X, Bonneau B, Roos-Weil D, Pinnetti C, Rauer S, Nitsch L, Del Bello A, Jelcic I, Sühs KW, Gasnault J, Goreci Y, Grauer O, Gnanapavan S, Wicklein R, Lambert N, Perpoint T, Beudel M, Clifford D, Sommet A, Cortese I, Martin-Blondel G; Immunotherapy for PML Study Group. Boumaza X, et al. Ann Neurol. 2023 Feb;93(2):257-270. doi: 10.1002/ana.26512. Epub 2022 Oct 17. Ann Neurol. 2023. PMID: 36151879 Free PMC article.
Nivolumab-induced sensory ganglionopathy.
Coskun O, Sahin H, Yalcin S, Sahin YC, Coskun U. Coskun O, et al. J Oncol Pharm Pract. 2023 Sep;29(6):1510-1515. doi: 10.1177/10781552231177712. Epub 2023 May 30. J Oncol Pharm Pract. 2023. PMID: 37254496
First-line avelumab in a cohort of 116 patients with metastatic Merkel cell carcinoma (JAVELIN Merkel 200): primary and biomarker analyses of a phase II study.
D'Angelo SP, Lebbé C, Mortier L, Brohl AS, Fazio N, Grob JJ, Prinzi N, Hanna GJ, Hassel JC, Kiecker F, Georges S, Ellers-Lenz B, Shah P, Güzel G, Nghiem P. D'Angelo SP, et al. J Immunother Cancer. 2021 Jul;9(7):e002646. doi: 10.1136/jitc-2021-002646. J Immunother Cancer. 2021. PMID: 34301810 Free PMC article. Clinical Trial.
An update on Merkel cell carcinoma.
Sergi MC, Lauricella E, Porta C, Tucci M, Cives M. Sergi MC, et al. Biochim Biophys Acta Rev Cancer. 2023 May;1878(3):188880. doi: 10.1016/j.bbcan.2023.188880. Epub 2023 Mar 11. Biochim Biophys Acta Rev Cancer. 2023. PMID: 36914034 Review.
Immunotherapy for Merkel Cell Carcinoma.
Nagase K, Narisawa Y. Nagase K, et al. Curr Treat Options Oncol. 2018 Sep 20;19(11):57. doi: 10.1007/s11864-018-0574-5. Curr Treat Options Oncol. 2018. PMID: 30238195 Review.
Brincidofovir inhibits polyomavirus infection in vivo.
Butic AB, Katz ZE, Jin G, Fukushima K, Hazama M, Lukacher AE, Lauver MD. Butic AB, et al. mBio. 2024 Aug 14;15(8):e0104924. doi: 10.1128/mbio.01049-24. Epub 2024 Jul 2. mBio. 2024. PMID: 38953354 Free PMC article.
842 results